avilamycin has been researched along with evernimicin in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aarestrup, FM | 1 |
| Aarestrup, FM; Jensen, LB | 1 |
| Aarestrup, FM; McNicholas, PM | 1 |
| Belanger, AE; Shryock, TR | 1 |
| Bachmann, BO; Du, Y; Gitschlag, BL; Iverson, TM; Mathieu, JL; McCranie, EK; McCulloch, KM; Sarwar, M; Smith, JA | 1 |
| Arenz, S; Blanchard, SC; Graf, M; Huter, P; Juette, MF; Nguyen, F; Polikanov, YS; Wilson, DN | 1 |
| Bashan, A; Diskin Posner, Y; Eyal, Z; Krupkin, M; Matzov, D; Rozenberg, H; Wekselman, I; Yonath, A; Zimmerman, E | 1 |
7 other study(ies) available for avilamycin and evernimicin
| Article | Year |
|---|---|
Association between decreased susceptibility to a new antibiotic for treatment of human diseases, everninomicin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin.
Topics: Aminoglycosides; Animal Feed; Animals; Anti-Bacterial Agents; Chickens; Drug Resistance, Microbial; Drug Utilization; Enterococcus; Gram-Positive Bacterial Infections; Growth Substances; Humans; Microbial Sensitivity Tests; Oligosaccharides; Swine | 1998 |
Presence of variations in ribosomal protein L16 corresponding to susceptibility of enterococci to oligosaccharides (Avilamycin and evernimicin).
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; DNA, Bacterial; Enterococcus; Genetic Variation; Microbial Sensitivity Tests; Molecular Sequence Data; Oligosaccharides; Ribosomal Proteins | 2000 |
Incidence of high-level evernimicin resistance in Enterococcus faecium among food animals and humans.
Topics: Aminoglycosides; Animal Feed; Animals; Anti-Bacterial Agents; Cattle; Chickens; Conjugation, Genetic; Denmark; Diarrhea; Drug Resistance; Enterococcus faecium; Humans; Methyltransferases; Oligosaccharides; Reverse Transcriptase Polymerase Chain Reaction; Swine | 2002 |
Avilamycin did not play a role in the discontinuation of evernimicin as a clinical drug candidate.
Topics: Aminoglycosides; Animals; Clinical Trials, Phase III as Topic; Drug Resistance, Bacterial; Gas Chromatography-Mass Spectrometry; Humans; Molecular Conformation; Molecular Structure; Oligosaccharides | 2005 |
Oxidative cyclizations in orthosomycin biosynthesis expand the known chemistry of an oxygenase superfamily.
Topics: Aminoglycosides; Anti-Bacterial Agents; Catalytic Domain; Crystallography, X-Ray; Cyclization; Hydrogen; Hygromycin B; Metals; Micromonospora; Multigene Family; Oligosaccharides; Open Reading Frames; Oxidation-Reduction; Oxygen; Oxygenases; Phylogeny; Protein Binding; Protein Structure, Secondary; Reproducibility of Results; Streptomyces | 2015 |
Structures of the orthosomycin antibiotics avilamycin and evernimicin in complex with the bacterial 70S ribosome.
Topics: Amino Acid Sequence; Aminoglycosides; Anti-Bacterial Agents; Binding Sites; Cryoelectron Microscopy; Escherichia coli; Molecular Sequence Data; Molecular Structure; Oligosaccharides; Peptide Chain Elongation, Translational; Ribosome Subunits, Large, Bacterial; Single Molecule Imaging | 2016 |
Avilamycin and evernimicin induce structural changes in rProteins uL16 and CTC that enhance the inhibition of A-site tRNA binding.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Binding Sites; Crystallography, X-Ray; Drug Resistance, Bacterial; Gram-Positive Bacteria; Microbial Sensitivity Tests; Models, Molecular; Mutation; Nucleic Acid Conformation; Oligosaccharides; Protein Biosynthesis; Ribosomal Proteins; Ribosomes; RNA, Ribosomal; RNA, Ribosomal, 23S; RNA, Transfer; Sequence Alignment; Species Specificity | 2016 |